Form S-3 - Registration statement under Securities Act of 1933:
SEC Accession No. 0001628280-22-008431
Filing Date
2022-04-05
Accepted
2022-04-05 17:19:35
Documents
11

Document Format Files

Seq Description Document Type Size
1 S-3 crdfs-3040522.htm S-3 587555
2 EX-4.3 a43ex040522.htm EX-4.3 308899
3 EX-4.4 a44ex040522.htm EX-4.4 317774
4 EX-5.1 a51ex040522.htm EX-5.1 49229
5 EX-23.1 a231ex040522.htm EX-23.1 2878
6 EX-FILING FEES ex-filingfees.htm EX-FILING FEES 31937
7 cardiff_logoxrgbxtma.jpg GRAPHIC 176318
8 image_02.jpg GRAPHIC 34763
9 image_2.jpg GRAPHIC 127
10 image_210.jpg GRAPHIC 295
11 image_29.jpg GRAPHIC 302
  Complete submission text file 0001628280-22-008431.txt   1576841
Mailing Address 11055 FLINTKOTE AVENUE SAN DIEGO CA 92121
Business Address 11055 FLINTKOTE AVENUE SAN DIEGO CA 92121 858-952-7570
Cardiff Oncology, Inc. (Filer) CIK: 0001213037 (see all company filings)

EIN.: 272004382 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-3 | Act: 33 | File No.: 333-264148 | Film No.: 22808175
SIC: 2836 Biological Products, (No Diagnostic Substances)